Tenet Healthcare Corporation Company Profile (NYSE:THC)

About Tenet Healthcare Corporation (NYSE:THC)

Tenet Healthcare Corporation logoTenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company's segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children's hospitals, two specialty hospitals and one critical access hospital. The Company's Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities. As of December 31, 2016, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states. As of December 31, 2016, the Company operated 20 short-stay surgical hospitals, over 470 outpatient centers, and nine facilities in the United Kingdom.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Facilities
  • Symbol: NYSE:THC
  • CUSIP: 88033G40
  • Web: www.tenethealth.com
  • Market Cap: $1.48 billion
  • Outstanding Shares: 100,820,000
Average Prices:
  • 50 Day Moving Avg: $15.64
  • 200 Day Moving Avg: $16.92
  • 52 Week Range: $12.25 - $24.13
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 11.94
  • P/E Growth: 1.24
Sales & Book Value:
  • Annual Revenue: $19.32 billion
  • Price / Sales: 0.08
  • Book Value: $3.70 per share
  • Price / Book: 3.97
  • EBITDA: $2.07 billion
  • Net Margins: -0.97%
  • Return on Equity: -2.00%
  • Return on Assets: -0.09%
  • Debt-to-Equity Ratio: 14.23%
  • Current Ratio: 1.24%
  • Quick Ratio: 1.17%
  • Average Volume: 4.56 million shs.
  • Beta: 1.2
  • Short Ratio: 9.62

Frequently Asked Questions for Tenet Healthcare Corporation (NYSE:THC)

What is Tenet Healthcare Corporation's stock symbol?

Tenet Healthcare Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

How were Tenet Healthcare Corporation's earnings last quarter?

Tenet Healthcare Corporation (NYSE:THC) announced its earnings results on Monday, August, 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.17). The firm earned $14.80 billion during the quarter, compared to analysts' expectations of $4.90 billion. Tenet Healthcare Corporation had a negative return on equity of 2.00% and a negative net margin of 0.97%. The company's revenue was up 204.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.38 earnings per share. View Tenet Healthcare Corporation's Earnings History.

When will Tenet Healthcare Corporation make its next earnings announcement?

Tenet Healthcare Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Tenet Healthcare Corporation.

What guidance has Tenet Healthcare Corporation issued on next quarter's earnings?

Tenet Healthcare Corporation issued an update on its FY17 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of $0.69-0.99 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.20. The company issued revenue guidance of $19.1-19.4 billion, compared to the consensus revenue estimate of $19.74 billion.

Where is Tenet Healthcare Corporation's stock going? Where will Tenet Healthcare Corporation's stock price be in 2017?

15 analysts have issued 1 year price objectives for Tenet Healthcare Corporation's stock. Their forecasts range from $14.00 to $30.00. On average, they anticipate Tenet Healthcare Corporation's share price to reach $20.31 in the next twelve months. View Analyst Ratings for Tenet Healthcare Corporation.

What are analysts saying about Tenet Healthcare Corporation stock?

Here are some recent quotes from research analysts about Tenet Healthcare Corporation stock:

  • 1. According to Zacks Investment Research, "Tenet Healthcare’s shares have underperformed the industry in last one year. The company has a high level of uncollectible accounts despite several divestures. Rising level of bad debts over past few quarters has led to a spike in interest expenses that has been weighing on the margins. Its operating expenses have also been rising rapidly putting pressure on the bottom line. The company has seen its Zacks Consensus Estimate for 2017 and 2018 earnings being revised downward in last 60 days. Following the lackluster second-quarter 2017 results, the company has lowered its guidance for 2017." (9/19/2017)
  • 2. Mizuho analysts commented, "Part of the job of an analyst is to connect disparate pieces of information in order to validate, reject or create an investment thesis. We connect THC's January comments about cost cutting initiatives & potential asset sales with reports from Detroit & other markets regarding the possible depth, immediacy and impact of those cuts, CYH's recent success with the same strategy and then estimate the potential impact on EBITDA and valuation. The conclusion we reach is that our Underperform rating was no longer valid. We raise our rating to Neutral and our PT to $22.80 from $13." (2/24/2017)

Are investors shorting Tenet Healthcare Corporation?

Tenet Healthcare Corporation saw a decline in short interest in the month of September. As of September 29th, there was short interest totalling 29,815,244 shares, a decline of 14.2% from the September 15th total of 34,730,269 shares. Based on an average daily volume of 3,246,223 shares, the short-interest ratio is presently 9.2 days. Approximately 30.2% of the company's shares are sold short.

Who are some of Tenet Healthcare Corporation's key competitors?

Who are Tenet Healthcare Corporation's key executives?

Tenet Healthcare Corporation's management team includes the folowing people:

  • Ronald A. Rittenmeyer, Executive Chairman of the Board
  • Trevor Fetter, President, Chief Executive Officer
  • Daniel J. Cancelmi, Chief Financial Officer
  • J. Eric Evans, President - Hospital Operations
  • Audrey T. Andrews, Senior Vice President and General Counsel
  • John P. Byrnes, Independent Director
  • Brenda J. Gaines, Independent Director
  • Karen M. Garrison, Independent Director
  • Edward A. Kangas, Independent Director
  • J. Robert Kerrey, Independent Director

Who owns Tenet Healthcare Corporation stock?

Tenet Healthcare Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (17.79%), GLENVIEW CAPITAL MANAGEMENT, LLC (17.79%), CAMBER CAPITAL MANAGEMENT LLC (5.70%), Nationwide Fund Advisors (0.19%) and Mutual of America Capital Management LLC (0.06%). Company insiders that own Tenet Healthcare Corporation stock include Glenview Capital Management, L, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare Corporation.

Who sold Tenet Healthcare Corporation stock? Who is selling Tenet Healthcare Corporation stock?

Tenet Healthcare Corporation's stock was sold by a variety of institutional investors in the last quarter, including Mutual of America Capital Management LLC. View Insider Buying and Selling for Tenet Healthcare Corporation.

Who bought Tenet Healthcare Corporation stock? Who is buying Tenet Healthcare Corporation stock?

Tenet Healthcare Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Nationwide Fund Advisors. Company insiders that have bought Tenet Healthcare Corporation stock in the last two years include Glenview Capital Management, L, Peter M Wilver and Ronald A Rittenmeyer. View Insider Buying and Selling for Tenet Healthcare Corporation.

How do I buy Tenet Healthcare Corporation stock?

Shares of Tenet Healthcare Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tenet Healthcare Corporation's stock price today?

One share of Tenet Healthcare Corporation stock can currently be purchased for approximately $14.69.

MarketBeat Community Rating for Tenet Healthcare Corporation (NYSE THC)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  349 (Vote Outperform)
Underperform Votes:  448 (Vote Underperform)
Total Votes:  797
MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tenet Healthcare Corporation (NYSE:THC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 10 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $20.31 (38.24% upside)
Consensus Price Target History for Tenet Healthcare Corporation (NYSE:THC)
Price Target History for Tenet Healthcare Corporation (NYSE:THC)
Analysts' Ratings History for Tenet Healthcare Corporation (NYSE:THC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/15/2017SunTrust Banks, Inc.Set Price TargetHold$15.00N/AView Rating Details
9/28/2017Robert W. BairdReiterated RatingBuy$23.00HighView Rating Details
9/25/2017Royal Bank Of CanadaReiterated RatingHold$19.00HighView Rating Details
9/21/2017Jefferies Group LLCReiterated RatingBuy$24.00LowView Rating Details
9/14/2017MizuhoReiterated RatingNeutral$14.00MediumView Rating Details
9/14/2017Citigroup Inc.Reiterated RatingHold$16.00MediumView Rating Details
9/1/2017Deutsche Bank AGReiterated RatingBuy$24.00LowView Rating Details
8/20/2017Leerink SwannReiterated RatingOutperform$23.00 -> $30.00HighView Rating Details
8/9/2017Credit Suisse GroupLower Price TargetNeutral$20.00 -> $17.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageEqual -> Equal Weight$19.00HighView Rating Details
6/6/2017Wells Fargo & CompanyUpgradeMarket Perform -> Outperform$22.00LowView Rating Details
1/3/2017Piper Jaffray CompaniesInitiated CoverageNeutral$16.00N/AView Rating Details
11/10/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016Bank of America CorporationDowngradeBuy -> Neutral$32.00 -> $25.00N/AView Rating Details
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/AView Rating Details
8/19/2016Barclays PLCReiterated RatingBuy$39.00N/AView Rating Details
6/13/2016Ladenburg Thalmann Financial ServicesUpgradeNot Rated -> UnderperformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
5/5/2016J P Morgan Chase & CoReiterated RatingHold$36.00N/AView Rating Details
4/13/2016Susquehanna Bancshares IncUpgradeNeutral -> Positive$38.00N/AView Rating Details
2/26/2016BMO Capital MarketsLower Price TargetOutperform$55.00 -> $38.00N/AView Rating Details
(Data available from 10/23/2015 forward)


Earnings History for Tenet Healthcare Corporation (NYSE:THC)
Earnings by Quarter for Tenet Healthcare Corporation (NYSE:THC)
Earnings History by Quarter for Tenet Healthcare Corporation (NYSE THC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.37)N/AView Earnings Details
8/7/2017Q2 2017($0.17)($0.17)$4.90 billion$14.80 billionViewListenView Earnings Details
5/1/2017Q1 2017($0.52)($0.27)$4.84 billion$4.81 billionViewListenView Earnings Details
2/27/2017Q416$0.22$0.06$4.95 billion$4.86 billionViewN/AView Earnings Details
10/31/2016Q316$0.17$0.16$2.28 billion$4.85 billionViewN/AView Earnings Details
8/1/2016Q216$0.52$0.38$4.82 billion$4.87 billionViewN/AView Earnings Details
5/2/2016Q116$0.34$0.45$4.79 billion$5.04 billionViewN/AView Earnings Details
2/22/2016Q415$0.34$0.35$4.82 billion$5.21 billionViewListenView Earnings Details
11/2/2015Q315$0.27$0.29$4.67 billion$4.69 billionViewN/AView Earnings Details
8/3/2015Q215$0.44$0.75$4.37 billion$4.49 billionViewN/AView Earnings Details
5/4/2015Q115$0.31$0.67$4.33 billion$4.43 billionViewN/AView Earnings Details
2/23/2015Q414$1.18$1.03$4.34 billion$4.82 billionViewN/AView Earnings Details
11/3/2014Q314$0.10$0.09$4.02 billion$4.18 billionViewListenView Earnings Details
8/4/2014Q214$0.01($0.27)$3.94 billion$4.04 billionViewN/AView Earnings Details
5/5/2014Q114($0.14)($0.12)$3.91 billion$3.93 billionViewListenView Earnings Details
2/24/2014Q413$0.37$0.49$3.87 billion$3.89 billionViewN/AView Earnings Details
11/5/2013Q313$0.45$0.45$2.38 billion$2.62 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.75($0.49)$2.46 billion$2.42 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.31$0.33$2.46 billion$2.59 billionViewListenView Earnings Details
2/26/2013Q4 2012$0.68$0.45$2.34 billion$2.33 billionViewListenView Earnings Details
11/7/2012Q312$0.32$0.34$2.42 billion$2.43 billionViewN/AView Earnings Details
8/7/2012$0.05$0.10ViewN/AView Earnings Details
5/8/2012$0.10$0.13ViewN/AView Earnings Details
2/28/2012$0.14$0.10ViewN/AView Earnings Details
11/1/2011$0.04ViewN/AView Earnings Details
8/2/2011$0.08$0.09ViewN/AView Earnings Details
5/3/2011$0.14$0.17ViewN/AView Earnings Details
2/25/2011$0.08$0.14ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Tenet Healthcare Corporation (NYSE:THC)
2017 EPS Consensus Estimate: $0.95
2018 EPS Consensus Estimate: $1.99
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175($0.60)$0.52($0.32)
Q2 20175($0.36)$0.40$0.00
Q3 20175($0.46)$0.37($0.24)
Q4 20175$0.81$1.80$1.51
Q1 20181$0.18$0.18$0.18
Q2 20181$0.41$0.41$0.41
Q3 20181$0.44$0.44$0.44
Q4 20181$0.96$0.96$0.96
(Data provided by Zacks Investment Research)


Dividend History for Tenet Healthcare Corporation (NYSE:THC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tenet Healthcare Corporation (NYSE:THC)
Insider Ownership Percentage: 3.10%
Insider Trades by Quarter for Tenet Healthcare Corporation (NYSE:THC)
Institutional Ownership by Quarter for Tenet Healthcare Corporation (NYSE:THC)
Insider Trades by Quarter for Tenet Healthcare Corporation (NYSE:THC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2016Ronald A RittenmeyerDirectorBuy15,000$14.35$215,250.00View SEC Filing  
11/9/2016Peter M WilverDirectorBuy5,000$15.19$75,950.00View SEC Filing  
11/13/2015Glenview Capital Management, LMajor ShareholderBuy900,000$32.56$29,304,000.00View SEC Filing  
10/22/2015Glenview Capital Management, LMajor ShareholderBuy500,000$29.71$14,855,000.00View SEC Filing  
9/30/2015Glenview Capital Management, LMajor ShareholderBuy500,000$36.30$18,150,000.00View SEC Filing  
8/25/2015Glenview Capital Management, LMajor ShareholderBuy500,000$48.39$24,195,000.00View SEC Filing  
7/14/2015Trevor FetterCEOSell96,477$60.40$5,827,210.80View SEC Filing  
7/13/2015Trevor FetterCEOSell88,004$60.08$5,287,280.32View SEC Filing  
7/6/2015Trevor FetterCEOSell83,443$60.02$5,008,248.86View SEC Filing  
6/25/2015Glenview Capital Management, LMajor ShareholderBuy979,482$54.93$53,802,946.26View SEC Filing  
6/25/2015Trevor FetterCEOSell47,711$55.02$2,625,059.22View SEC Filing  
6/4/2015R. Scott RamseyInsiderSell5,650$51.64$291,766.00View SEC Filing  
8/18/2014Trevor FetterCEOSell33,642$60.01$2,018,856.42View SEC Filing  
8/14/2014Britt T ReynoldsInsiderSell8,028$58.49$469,557.72View SEC Filing  
8/8/2014Audrey T AndrewsSVPSell2,208$56.31$124,332.48View SEC Filing  
8/8/2014Daniel J CancelmiCFOSell12,291$56.88$699,112.08View SEC Filing  
8/8/2014R. Scott RamseyInsiderSell2,083$56.27$117,210.41View SEC Filing  
8/7/2014Trevor FetterCEOSell138,665$56.12$7,781,879.80View SEC Filing  
7/25/2014Trevor FetterCEOSell41,000$51.34$2,104,940.00View SEC Filing  
6/9/2014Britt T ReynoldsInsiderSell35,000$49.82$1,743,700.00View SEC Filing  
5/22/2014Trevor FetterCEOSell35,394$47.52$1,681,922.88View SEC Filing  
5/15/2014Richard PettingillDirectorSell10,000$45.22$452,200.00View SEC Filing  
5/12/2014Edward KangasChairmanSell12,000$44.29$531,480.00View SEC Filing  
4/25/2014Trevor FetterCEOSell57,735$45.00$2,598,075.00View SEC Filing  
3/24/2014Audrey AndrewsSVPSell13,624$40.17$547,276.08View SEC Filing  
12/23/2013Glenview Capital Management, Lmajor shareholderBuy248,910$39.79$9,904,128.90View SEC Filing  
12/20/2013Glenview Capital Management, Lmajor shareholderBuy644,582$39.95$25,751,050.90View SEC Filing  
12/18/2013Glenview Capital Management, Lmajor shareholderBuy1,000,000$40.12$40,120,000.00View SEC Filing  
11/15/2013Keith PittsChairmanBuy6,250$43.13$269,562.50View SEC Filing  
11/14/2013Keith PittsChairmanBuy6,250$43.14$269,625.00View SEC Filing  
11/8/2013Keith PittsChairmanBuy7,500$41.85$313,875.00View SEC Filing  
11/7/2013Keith PittsChairmanBuy5,000$41.97$209,850.00View SEC Filing  
10/3/2013John Ellis BushDirectorSell16,582$45.10$747,848.20View SEC Filing  
9/19/2013John Ellis BushDirectorSell8,291$42.90$355,683.90View SEC Filing  
5/14/2013Glenview Capital Management, LMajor ShareholderSell4,000,000$47.75$191,000,000.00View SEC Filing  
3/5/2013Edward A KangasChairmanSell7,000$39.88$279,160.00View SEC Filing  
3/4/2013Trevor FetterCEOSell138,255$39.39$5,445,864.45View SEC Filing  
10/19/2012Glenview Capital Management LlMajor ShareholderBuy200,000$23.53$4,706,000.00View SEC Filing  
10/16/2012Glenview Capital Management LlMajor ShareholderBuy433,383$23.98$10,392,524.34View SEC Filing  
9/17/2012Glenview Capital Management LlMajor ShareholderBuy750,000$5.75$4,312,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Tenet Healthcare Corporation (NYSE:THC)
Latest Headlines for Tenet Healthcare Corporation (NYSE:THC)
Loading headlines, please wait.



Tenet Healthcare Corporation (THC) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.